Supplemental Comment from Peppies, LLC
AnonymousSupportBusiness
Summary: Ken Underwood, Founder of Peppies, LLC, submits a supplemental comment to disclose the company's commercial interest in the proposed action. He argues that the company supports the establishment of a legal, regulated, and tested pathway for bulk drug substances to ensure consumer safety and market accountability.
Supplement to my prior comment (Docket FDA-2025-N-6895) on behalf of Peppies, LLC: disclosure of interest, and support for a legal, tested, verified compounding pathway.